Jordan Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$1995
Buy Report View Sample

Published: December 08, 2022 Report Code: GDHC0045CHR-ST

Select Item

Jordan Healthcare Market Report Overview

The Jordan pharmaceutical market size was $1.16 billion and its medical devices market size was $595 million in 2021. Jordan’s healthcare industry is one of the fastest-growing industries in the nation due to its top-notch internationally certified workforce, cutting-edge medical technology, and excellent medical facilities.

Jordan is regarded as one of the most prominent medical tourism destinations in the Middle East and is a front-runner in pharmaceutical production in the Middle East and North Africa (MENA) region. As a result of factors like increased medical tourism from Saudi Arabia and other Gulf Cooperation Council (GCC) nations, Jordan is expected to experience further growth in the coming years.

The Jordan healthcare market research report is an essential source of information on the analysis of the healthcare, regulatory, and reimbursement landscape in Jordan. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets.

Jordan Pharmaceutical Market Overview

Jordan Pharmaceutical Market Overview

 To gain more information on the Jordan pharmaceutical market forecast, download a free report sample

Jordan Medical Devices Market Overview

Jordan Medical Devices Market OverviewTo gain more information on the Jordan medical devices market forecast, download a free report sample

Jordan Pharmaceuticals Market Segmentation by Import and Export Partners

The key import partners of Jordan pharmaceuticals market are the US, Germany, France, Italy, Switzerland, and others. The US accounts for the highest percentage of the import business.

The key export partners of Jordan pharmaceuticals market are Saudi Arabia, Iraq, the US, Algeria, UAE, and others. Saudi Arabia accounts for the highest percentage of the export business.

Jordan Pharmaceuticals Market Analysis by Import Partners

Jordan Pharmaceuticals Market Analysis by Import PartnersFor more import partner insights into the Jordan pharmaceuticals market, download a free report sample

Jordan Pharmaceuticals Market Analysis by Export Partners

Jordan Pharmaceuticals Market Analysis by Export PartnersFor more export partner insights into the Jordan pharmaceuticals market, download a free report sample

Jordan Pharmaceuticals Market Segments

The key segments in the Jordan pharmaceuticals market are generics, biologics, biosimilars, and over-the-counter (OTC) medicines.

Jordan Pharmaceuticals Market – Competitive Landscape

The leading players in the Jordan pharmaceuticals market are Pfizer, Novartis, GlaxoSmithKline (GSK), JPM, and Sanofi. Pfizer led the Jordan pharmaceuticals market in 2021.

Jordan Pharmaceuticals Market Analysis by Players

Jordan Pharmaceuticals Market Analysis by PlayersTo know more about leading players in the Jordan pharmaceuticals market, download a free report sample

Jordan Medical Devices Market – Competitive Landscape

The major players in the medical devices market of Jordan are Roche, Abbott, Medtronic, Fresenius, and Stryker. Roche led the medical devices market in Jordan in 2021.

Jordan Medical Devices Market Analysis by Players

Jordan Medical Devices Market Analysis by PlayersTo know more about leading players in the Jordan medical devices market, download a free report sample

Jordan Pharmaceuticals Market Report Overview

Market Size (2021) $1.16 billion
Key Segments Generics, Biologics, Biosimilars, and Over-the-Counter (OTC) Medicines
Key Import Partners The US, Germany, France, Italy, Switzerland, and Others
Key Export Partners Saudi Arabia, Iraq, The US, Algeria, UAE, and Others
Leading Players Pfizer, Novartis, GlaxoSmithKline (GSK), JPM, and Sanofi

Jordan Medical Devices Market Report Overview

Market Size (2021) $595 million
Leading Players Roche, Abbott, Medtronic, Fresenius, and Stryker

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Jordan, and includes:

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
  • Profiles and SWOT analyses of the major players in the pharmaceutical market.
  • Profiles and SWOT analyses of the major players in the medical device market.
  • An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in the healthcare market, HealthTech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies, and the approval processes for new drugs and medical devices.
  • Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure, and healthcare expenditure.
  • An overview of the opportunities for and challenges to growth in the Jordan healthcare market.

Reasons to Buy

This report will enhance your decision-making capability by allowing you to:

  • Develop business strategies by understanding the trends shaping and driving the Jordan healthcare market

  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the Jordan healthcare market in the future

  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance

  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

Table of Contents

1. Table of Contents

1.1 List of Figures

1.2 List of Tables

2. Executive Summary

2.1 Executive Summary

2.2 Key Highlights: Facts About the Jordanian Healthcare Market

2.3 Key Highlights: Healthcare Startups in Jordan

2.4 Key Events: Jordanian Healthcare Timeline, 2016–22

2.5 Key Events: Jordanian Pharmaceutical Market

2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2021–22

2.7 Key Events: Top Completed Deals by Value, 2022

2.8 Country Profile, Jordan, 2021

3. Overview of Pharmaceutical Market

3.1 Pharmaceutical Market – Overview

3.2 Pharmaceutical Market – Exports

3.3 Pharmaceutical Market – Imports

3.4 Pharmaceutical Market – Supply Channels, Jordan

3.5 Pharmaceutical Market – Medical Tourism, Jordan

3.6 Pharmaceutical Market – Market Segments

3.7 COVID-19 Epidemiology, Jordan

3.8 COVID-19 Impact and Developments in the Healthcare Market, Jordan

3.9 COVID-19 Clinical Trials Landscape, Jordan

3.10 Pharmaceutical Market – Major Players

4. Overview of Medical Devices Market

4.1 Medical Device Market – Overview

4.2 Medical Devices Market – Major Players

5. Pharmaceutical and Medical Devices Market – Drivers and Barriers

5.1 Drivers

5.2 Barriers

6. Deal Analysis

6.1 Deal Analysis: Pharmaceutical Market, Jordan, 2020–22

6.2 Deal Analysis: Medical Devices Market, Jordan, 2020–22

7. HealthTech Landscape

7.1 HealthTech Landscape, Jordan

7.2 Key Healthtech Deals, Jordan

7.3 Adoption of Technology in Healthcare, Jordan

7.4 Digital Regulations, Jordan

7.5 HealthTech Landscape: Benefits and Risks, Jordan

8. Market Access

8.1 Overview of Healthcare System, Jordan

8.2 Reimbursement Landscape, Jordan

8.3 Overview of Insurance Providers, Jordan

8.4 Healthcare Spending and Prescription Drug Price Trend, Jordan

8.5 Pricing Policies, Jordan

8.6 Market Access: Key Events Timeline, Jordan, 2010–22

8.7 Regulatory Landscape, Jordan

8.7.1 Marketing Authorization for Pharmaceutical Products, Jordan

8.7.2 Marketing Authorization for Medical Devices, Jordan

8.7.3 Intellectual Property Rights, Patents, Jordan

8.7.4 Intellectual Property Rights, Trademark, Jordan

8.7.5 Clinical Trial Regulations, Jordan

8.7.6 Pharmaceutical Clinical Trials Landscape, Jordan

8.7.7 Medical Devices Clinical Trials Landscape, Jordan

8.7.8 Pharmaceutical Imports and Exports, Jordan

8.7.9 Pharmaceutical Advertising Regulations, Jordan

8.7.10 Pharmacy Regulations, Jordan

8.7.11 Labeling and Packaging Regulations, Jordan

9. Country Healthcare Landscape

9.1 Jordanian Healthcare Policy Highlights

9.2 Healthcare Facilities, Jordan

9.3 Life Expectancy and Immunization Rate, Jordan

9.4 Environmental Health, Jordan

9.5 Healthcare Personnel, Jordan

9.6 Disease Burden, Jordan

9.7 Healthcare Expenditure, Jordan

10 Trade Associations, Jordan

11 Trade Fairs, Jordan

12 Opportunities and Challenges

13 Appendix

13.1 Research Methodology

13.1.1 Coverage

13.1.2 Secondary Research

13.1.3 Forecasts

13.2 Bibliography

13.3 About GlobalData

13.4 Contact Us

13.5 Disclaimer

Table

Table 1: COVID-19 indicators (number of cases), global and Jordan, 2022

Table 2: Approved vaccines, Jordan, 2022

Table 3: Patent fee, Jordan, 2022

Table 4: Trademark fees, Jordan, 2022

Table 5: Label on the blister package, Jordan, 2022

Table 6: Product insert (leaflet) information, Jordan, 2022

Table 7: Label of small pack, Jordan, 2022

Table 8: Trade fairs, Jordan, 2022

Figures

Figure 1: Pharmaceutical market, revenue ($B), Jordan, 2014–21

Figure 2: Medical devices market, revenue ($M), Jordan, 2015–21

Figure 3: Healthcare start-ups in Jordan, 2022

Figure 4: Country profile, Jordan, 2021

Figure 5: Pharmaceutical market, revenue ($B), Jordan, 2012–21

Figure 6: Pharmaceutical market, revenue forecast ($M), Jordan, 2022–27

Figure 7: Pharmaceutical exports ($B), Jordan, 2014–20

Figure 8: Top export partners, Jordan, 2020

Figure 9: Pharmaceutical imports ($M), Jordan, 2014–20

Figure 10: Top import partners, Jordan, 2020

Figure 11: MOH drug distribution process, Jordan, 2022

Figure 12: Private sector drug distribution process, Jordan, 2022

Figure 13: Public sector drug procurement process, Jordan, 2022

Figure 14: Reasons to travel to Jordan for medical treatment, 2022

Figure 15: COVID-19 cases, Jordan, 2020–22

Figure 16: COVID-19 deaths, Jordan, 2020–22

Figure 17: COVID-19 stringency index (based on the share of people who are vaccinated), Jordan, 2020–22

Figure 18: COVID-19 containment and health index, Jordan, 2020–22

Figure 19: COVID-19 clinical trials count by trial status, Jordan, 2020–22

Figure 20: COVID-19 clinical trials count by trial phase, Jordan, 2020–22

Figure 21: Top COVID-19 clinical trials sponsors by trial count, Jordan, 2020–22

Figure 22: Medical devices market, revenue ($M), Jordan, 2015–21

Figure 23: Medical devices market, revenue forecast ($M), Jordan, 2022–27

Figure 24: Medical devices market, revenue ($B) of major companies, Jordan, 2021

Figure 25: Deal value and deal count, pharmaceutical market, Jordan, 2020–22

Figure 26: Deal value and deal count subtypes, pharmaceutical market, Jordan, 2020–22

Figure 27: Deal value and deal count, quarterly, pharmaceutical market, Jordan, 2020–22

Figure 28: Top therapy areas by deal value ($M), pharmaceutical market, Jordan, 2020–22

Figure 29: Top therapy areas by deal count, pharmaceutical market, Jordan, 2020–22

Figure 30: Deal value and deal count, medical devices market, Jordan, 2020–22

Figure 31: Deal value and deal count subtypes, medical devices market, Jordan, 2020–22

Figure 32: Deal value and deal count, quarterly, medical devices market, Jordan, 2019–22

Figure 33: Top equipment sectors by deal value ($M), medical devices market, Jordan, 2020–22

Figure 34: Top equipment sectors by deal count, medical devices market, Jordan, 2020–22

Figure 35: M&A deals by quarter, medical devices market, Jordan, 2020–22 (by value and by number)

Figure 36: VC deals by quarter, medical devices market, Jordan, 2020–22 (by value and by number)

Figure 37: Core values of the ministry of digital economy and entrepreneurship, Jordan, 2022

Figure 38: Key performance indicators as per the national digital transformation strategy and implementation plan 2021–25, Jordan

Figure 39: Emerging technologies as per the national digital transformation strategy and implementation plan 2021–25, Jordan

Figure 40: Strength enablers as per the national digital transformation strategy and implementation plan 2021–25, Jordan

Figure 41: Digital transformation timeline as per the national digital transformation strategy and implementation plan 2021–25, Jordan

Figure 42: Overview of healthcare system, Jordan, 2022

Figure 43: Categories covered by military health insurance, Jordan, 2022

Figure 44: Timeline of civil health insurance, Jordan, 2022

Figure 45: OOP expenditure (% of total expenditure on health), Jordan, 2011–22

Figure 46: Consumer price index, monthly price index numbers (2018=100), Jordan, 2022

Figure 47: Countries referred for calculating the drug pricing through the median method, Jordan, 2022

Figure 48: Organization structure of regulatory agencies, Jordan, 2022

Figure 49: Drug application type selection, Jordan, 2022

Figure 50: Medical device approval process, Jordan, 2022

Figure 51: Patent approval process, Jordan, 2022

Figure 52: Trademark approval process, Jordan, 2022

Figure 53: Pharmaceutical clinical trials count by trial status, Jordan, 2020–22 and by number

Figure 54: Pharmaceutical clinical trials count by therapy areas, Jordan, 2020–22

Figure 55: Pharmaceutical clinical trials count by phase, Jordan, 2020–22

Figure 56: Top five pharmaceutical clinical trial sponsors by count, Jordan, 2020–22

Figure 57: Medical devices clinical trials count by trial status, Jordan, 2020–22

Figure 58: Medical devices clinical trials count by therapy areas, Jordan, 2020–22

Figure 59: Medical devices clinical trials count by market categories, Jordan, 2020–22

Figure 60: Top medical devices clinical trials sponsors by count, Jordan, 2020–22

Figure 61: Number of hospitals, Jordan, 2016–21

Figure 62: Number of hospital beds per 10,000 population, Jordan, 2013–21

Figure 63: Life expectancy at birth (years), Jordan, 2013–20

Figure 64: Immunization rate (%), Jordan, 2013–20

Figure 65: PM2.5 (µg per m3), Jordan, 2013–19

Figure 66: CO2 emissions (metric tons per capita), Jordan, 2013–20

Figure 67: Physicians (per 10,000 population), Jordan, 2013–21

Figure 68: Pharmacists (per 10,000 population), Jordan, 2013–21

Figure 69: Dentists (per 10,000 population), Jordan, 2013–21

Figure 70: Nurses and midwives (per 10,000 population), Jordan, 2013–21

Figure 71: Major causes of mortality (per 100,000 population), Jordan, 2019

Figure 72: Major causes of male mortality (per 100,000 population), Jordan, 2019

Figure 73: Major causes of female mortality (per 100,000 population), Jordan, 2019

Figure 74: DALYs by major disease (per 100,000 population), Jordan, 2019

Figure 75: Healthcare expenditure as percentage of GDP (%), Jordan, 2013–19

Figure 76: Health expenditure share (% of current health spending), Jordan, 2013–19

Frequently asked questions

Jordan Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape standard reports
Currency USD
$1,995

Can be used by individual purchaser only

Most Popular
$2,992

Can be shared by unlimited users within one corporate location e.g. a regional office

$3,990

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Jordan Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Pharmaceuticals reports
Pharmaceuticals
New
Insulin Receptor - Drugs In Development, 2024
$3,500 | June 2024
Pharmaceuticals
New
5-Hydroxytryptamine Receptor 2A - Drugs In Development, 2024
$3,500 | June 2024
Pharmaceuticals
New
Mu Type Opioid Receptor - Drugs In Development, 2024
$3,500 | June 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Jordan Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape in real time.

  • Access a live Jordan Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more